Diagnosis and therapeutic strategies for small bowel vascular lesions.
Study Goal
The researchers aimed to evaluate the role of iron supplementation as a conservative treatment option for patients with mild anemia caused by small bowel vascular lesions.
Results Summary
The study suggests that iron supplementation is a viable option for managing mild anemia in patients with small bowel vascular lesions, particularly when other treatments are ineffective or contraindicated. However, it does not provide specific data on the efficacy of iron supplementation compared to other treatments.
Population
Patients with mild anemia due to small bowel vascular lesions (e.g., angioectasia, Dieulafoy's lesion, arteriovenous malformation).
Effective Dosage
Not specified
Duration
Not specified
Interactions
None mentioned
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
deep enteroscopy | decrease | active bleeding | patients with small bowel vascular lesions | - | can be applied to control | #1 |
deep enteroscopy | decrease | anemia necessitating blood transfusion | patients with small bowel vascular lesions | - | can be applied to improve | #2 |
argon plasma coagulation (APC) | decrease | bleeding from angioectasia | patients with small bowel angioectasia | - | initial treatment efficacy | #3 |
argon plasma coagulation (APC) | increase | bleeding from Dieulafoy's lesion | patients with Dieulafoy's lesion | - | high re-bleeding rate after | #4 |
pharmacological treatments | decrease | bleeding from small bowel vascular lesions | patients who have not responded well to other treatments or in whom endoscopy is contraindicated | - | can be considered for patients who have not responded well | #5 |
iron supplementation | decrease | mild anemia | patients with mild anemia from small bowel vascular lesions | - | remains an option | #6 |
mechanical hemostasis using endoclips | decrease | Dieulafoy's lesions | patients with Dieulafoy's lesion | - | is recommended to treat | #7 |
surgical resection | decrease | small bowel arteriovenous malformations | patients with large, re-bleeding small bowel AVMs | - | usually require | #8 |
Small bowel vascular lesions, including angioectasia (AE), Dieulafoy's lesion (DL) and arteriovenous malformation (AVM), are the most common causes of obscure gastrointestinal bleeding. Since AE are considered to be venous lesions, they usually manifest as a chronic, well-compensated condition. Subsequent to video capsule endoscopy, deep enteroscopy can be applied to control active bleeding or to improve anemia necessitating blood transfusion. Despite the initial treatment efficacy of argon plasma coagulation (APC), many patients experience re-bleeding, probably because of recurrent or missed AEs. Pharmacological treatments can be considered for patients who have not responded well to other types of treatment or in whom endoscopy is contraindicated. Meanwhile, a conservative approach with iron supplementation remains an option for patients with mild anemia. DL and AVM are considered to be arterial lesions; therefore, these lesions frequently cause acute life-threatening hemorrhage. Mechanical hemostasis using endoclips is recommended to treat DLs, considering the high re-bleeding rate after primary APC cauterization. Meanwhile, most small bowel AVMs are large and susceptible to re-bleeding therefore, they usually require surgical resection. To achieve optimal diagnostic and therapeutic approaches for each type of small bowel lesion, the differences in their epidemiology, pathology and clinical presentation must be understood.